Snoop Dogg Down With Israeli Cannabis Company, Highlights Investment in the Country -- CFN Media

Seattle, Washington--(Newsfile Corp. - October 31, 2019) - CFN Media, the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Isracann Biosciences (CSE: IPOT).

Vocal cannabis activist Snoop Dogg has signed on as a brand ambassador for Israeli start-up Seedo, the maker of a refrigerator-type of a machine for auto-growing plants, including cannabis. The indelible award-winning rapper says he's "all the way down with" the Seedo Homelab and the utility it brings to allow people to grow their own plants in unused space at home.

With the help of Snoop, Seedo is one of a handful of companies making news that complements the storied history of cannabis in Israel that includes the discovery of cannabinoids decades ago and the passage of legislation this year that makes the country one of only of a small group in the world allowed to export cannabis.

Another company that is etching its name in Israeli cannabis business is Isracann Biosciences (CSE: IPOT) (OTC: ATLED), the first pure-play cannabis firm in the country to list in Canada.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/5503/49292_77737440c4476b4a_001.jpg

Isracann Biosciences (CSE: IPOT)

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/5503/49292_77737440c4476b4a_001full.jpg

Technology in Israel

Seedo's smell-proof, self-contained cultivation box lets users with no previous agriculture experience produce "brag worthy yields" with little more effort than planting a seed and monitoring the process through an app. The world's first fully automated and controlled indoor growing machine drums up memories of the old hands-off, "set it and forget it" Ronco rotisserie.

Snoop Dogg, whose real name is Calvin Cordozar Broadus Jr., will partner with Seedo on a variety of initiatives generating awareness of the innovative technology and the environmental benefits and social opportunity affiliated with it.

On a larger scale, Isracann is developing commercial-scale cultivation capacity and finding strong investors support to execute on the model, as indicated by a recent C$10.1 million financing round. The money is earmarked in part to build-out 230,000 square feet of the company's phase 1 facility. The initial phase will have capacity of 23,500 kilograms of cannabis per annum.

Click Here To Receive Isracann's Investor Presentation

Benefiting from the latest hybrid greenhouse technology and the near-perfect weather conditions in Israel for growing cannabis, management estimates that it will be able to produce its high-quality cannabis for as little as 40 cents per gram, a favorable production price for premium product.

Everything Coming Together

Isracann said on Monday that its current cash position allows for accelerating Phase 1 of the construction program, which includes:

  • finalization of greenhouse facility design for cannabis cultivation and production;
  • rapidly advancing greenhouse and related facility construction;
  • ensuring adequate controls are in place against any diversion, theft and loss of cannabis products; and
  • ensuring compliance with other protective security, health, and safety requirements in accordance with Israeli regulations

As milestones with the production facility draw nearer, Isracann has already entered into agreements for medical cannabis cultivation projects in Israel with local licensed stakeholders.

The anonymous stakeholder is shouldering part of the responsibility of the construction of the Isracann greenhouses, as well as bearing the cost of electricity, licenses, and property and related land taxes for the large cultivation and processing facility.

Click Here To Receive Isracann's Investor Presentation

Piquing interest that there are more positive developments on the horizon, Isracann CEO Darryl Jones said on Monday, "We have lined up several key organizations and personnel and look forward to announcing a number of these key commercial agreements in the days and weeks ahead."

Beyond addressing the underserved domestic market, Isracann has established distribution resources to leverage the export-friendly Israeli laws to send its future cannabis goods into the massive European markets.

Team Gets Stronger with Deepened Roots is Israel

Isracann's leadership includes the likes of Nitin Kaushal (managing director with PwC), Brett Allan (founding member The Green Organic Dutchman, VP Corporate Development Organigram and Justin Cooper (co-owner of Green Planet, the largest privately-owned hydroponics chain in Canada).

Now, the company has added Dr. Irit Arbel to its Board of Directors. Dr. Arbel has decades of multi-disciplinary biopharma, technology and governance experience. A serial entrepreneur, she has founded, held C-suite positions and other senior roles at companies such as Brainstorm Cell Therapeutics, Pluristem Life Sciences, Neurocords, Ltd., Savicell Diagnostics and RFB Investment House.

There is certainly an Israeli connection here with Dr. Arbel. She was previously an Israeli Sales Manager for the pharma Merck, Sharp & Dohme. She also holds a Chemical Engineering degree from the Technion, Israel's Institute of Technology.

To learn more about Isracann Biosciences Click Here

Click Here To Receive Isracann's Investor Presentation

Click Here to Receive CFN Media's Newsletter Every Week in Your Inbox

Please follow the link to read the full article on CFN Media: http://bit.ly/2Wq2Lxu

About CFN Media

CFN Enterprises Inc. (OTCQB: CNFN) is the owner and operator of CFN Media, the leading agency and digital financial media network dedicated to the legal cannabis industry.

For Visitors and Viewers

CFN Media's Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.

For Cannabis Businesses & Companies

CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.

Our powerful digital media and distribution platform conveys a company's message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.

Since 2013, CFN Media has enabled the world's preeminent cannabis companies to thrive in the capital and public markets.

Learn how to become a CFN Media client company, brand or entrepreneur: https://www.cannabisfn.com/become-featured-company/

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Isracann Contact:

Darryl Jones
Investor Relations
+1(604) 343-8661

info@isracann.com
www.isracann.com

Frank Lane
206-369-7050
Flane@cannabisfn.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49292

info